Glycine

Glycine

SCHEMBL7122600

CC(N)O.NCC(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL5921300 0.90
Glycine SCHEMBL4942685 0.90 GLRA1 (0.67)
Glycine SCHEMBL20471926 0.90 GLRA1 (0.67)
Glycine SCHEMBL7944810 0.90
Glycine SCHEMBL29180544 0.90 GLRA1 (0.67)
Glycine SCHEMBL28263992 0.88 GLRA1 (0.62)
Alanine SCHEMBL25189736 0.85 GLRA1 (0.59)
Alanine SCHEMBL1675385 0.85 GLRA1 (0.59)
D-Alanine SCHEMBL1537294 0.85 GLRA1 (0.59)
Alanine SCHEMBL2083490 0.85 GLRA1 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0720485-B1 METHOD OF ACTIVATING SOLUBLE CARBOHYDRATE USING NOVEL CYANYLATING REAGENTS FOR THE PRODUCTION OF IMMUNOGENIC CONSTRUCTS JACKSON H M FOUND MILITARY MED (US) 2003-11-19 EP disclosed
EP-0720485-A1 METHOD OF ACTIVATING SOLUBLE CARBOHYDRATE USING NOVEL CYANYLATING REAGENTS FOR THE PRODUCTION OF IMMUNOGENIC CONSTRUCTS HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE (US) 1996-07-10 EP disclosed
WO-1995008348-A1 METHOD OF ACTIVATING SOLUBLE CARBOHYDRATE USING NOVEL CYANYLATING REAGENTS FOR THE PRODUCTION OF IMMUNOGENIC CONSTRUCTS HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE (US) 1995-03-30 WO disclosed